Pink Sheet reporters and editors discuss the performance of the leaders of several coronavirus vaccine manufacturers during a recent congressional hearing and discuss proposed changes to the generic and prescription drug user fee programs.

In this edition of Device Week, Medtech Insight discuss second quarter results from some of medtech’s biggest companies and new guidelines for elective orthopedic surgery to minimize the risk of COVID-19 infection in hospitals.

For more information on Medtech Insight and to start a free trial, click here: http://bit.y/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

- Philips Sales Slide In Q2 But COVID-19 Drives Growth In Connected Care: https://bit.ly/2WPSNac

- Abbott Sees Signs Of Post-Pandemic Recovery In Q2: https://bit.ly/2EdnHmd

- J&J Bullish On Procedure Recovery As Q2 Device Sales Beat Analyst Expectations: https://bit.ly/2OPIKgM

- Hip And Knee Surgeons Offer Recommendations For Resuming Elective Surgeries To Reduce Risk Of COVID-19: https://bit.ly/2OPIKgM

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

Craft the perfect entry for the 2020 #GGBAwards with our experts in this Entry Guideline Podcast. Entries close on August 14th 2020.

In this Device Week, Medtech Insight’s Amanda Maxwell reviews the EU regulatory outlook for device companies against the backdrop of COVID-19 and consequent delay in the MDR application date, the knock-on effects on the IVDR, and the pressures being felt by notified bodies.

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

In this week’s podcast, Medtech Insight's managing editor Marion Webb chats with editor-in-chief Phil Greenfield about start-up Protaryx Medical, which raised $8.3m to develop its first-in-class device for transseptal access to the left atrium. Deputy editor Reed Miller discusses proposed updates by the Centers for Medicare and Medicaid Services for coverage of transcatheter mitral valve repair and reporter Catherine Longworth talks about her Exec Chat with Angelo De Rosa, VP of Boston Scientific’s cardiac rhythm management business about opportunities for digital transformation in health care.

Listen to the podcast via the player below:

CMS Proposes Coverage Policy For Transcatheter Edge-to-Edge Mitral Valve Repair

https://bit.ly/3efqac1

Start-Up Spotlight: Protaryx Aims To Simplify Transseptal Access

https://bit.ly/2O4AQQ7

Exec Chat: Boston Scientific’s Angelo De Rosa Forsees Digital Transformation In The COVID-19 Era

https://bitly.is/31YTIIC

For more information on Medtech Insight and to start a free trial, click here:

http://bit.ly/2w7LnlR

With the CPhI Pharma Awards going Digital in 2020, what does that mean for entries? Get an insight into crafting the perfect entry in our latest podcast

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

Summary:

This week's Device Week podcast covers recent regulatory developments in Asia in the wake of COVID-19, and how regulators are adjusting to working under the pandemic. Having published two updates from our regular Asian Medtech Associations Reg Networking discussions this week, Medtech Insight speaks to Asia Regulatory Professional Association founder Jack Wong on Asian regulatory themes and South Korea's hosting of the next International Medical Device School.

In this Device Week, we speak to Singapore-based regulatory specialist Jack Wong, founder of the Asia Regulatory Professional Association, and go deeper into the regional Asian themes explored in our twin regulatory updates published this week. ([A#MT142362]) and ([A#MT142364])

The first half of the podcast is a discussion of the benefits – or otherwise – of a move to a virtual working environment for medtech regulatory affairs professionals, and the priorities now and in the future as the incidence COVID-19 continues to be brought under control in the Asian economies. The second half addresses the need for greater awareness and training in the sector generally, and describes the remit and next stages of the new International Medical Device School.